Lipofectamine-Mediated CRISPR-Cas9 Delivery Targeting the MecA Gene in Methicillin-Resistant Staphylococcus Aureus: A Novel Approach to Reverse Antibiotic Resistance. WAJHN 2026, 2 (2), 27-35. https://doi.org/10.63954/bantev40.